Cargando…
New approaches for patients with advanced radioiodine-refractory thyroid cancer
The cumulative evidence over the past decades has shown that the incidence of differentiated thyroid carcinoma (DTC) has exponentially increased. Approximately 10% of patients with DTC exhibit recurrent or metastatic disease, and about two-thirds of the latter will be defined as refractory to radioa...
Autores principales: | Pitoia, Fabián, Jerkovich, Fernando, Trimboli, Pierpaolo, Smulever, Anabella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790300/ https://www.ncbi.nlm.nih.gov/pubmed/35116229 http://dx.doi.org/10.5306/wjco.v13.i1.9 |
Ejemplares similares
-
Active surveillance in low risk papillary thyroid carcinoma
por: Pitoia, Fabian, et al.
Publicado: (2020) -
Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience
por: Smulever, Anabella, et al.
Publicado: (2023) -
Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America
por: Smulever, Anabella, et al.
Publicado: (2019) -
Thyroid cancer in the Era of COVID-19
por: Smulever, Anabella, et al.
Publicado: (2020) -
Selective use of sorafenib in the treatment of thyroid cancer
por: Pitoia, Fabián, et al.
Publicado: (2016)